How much is Candid Therapeutics worth in 2026?

Candid Therapeutics has a current valuation of $657.0M based on their Early Stage VC round and secondary market data.

How much funding has Candid Therapeutics raised?

Candid Therapeutics has raised $445.0M in total funding across 1 funding rounds.

Candid Therapeutics

Drug DiscoveryWebsite

Candid Therapeutics valuation and funding history | Last updated: August 20, 2024 | 1 funding rounds

Current Valuation

$657.0M

As of August 20, 2024

Total Funding Raised

$445.0M

Across 1 round

Last Round

Early Stage VC

$370.0M

Last Funding

Aug 2024

Funding date

Capital Efficiency

1.48x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 20, 2024	Early Stage VC (Series B)	$370.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Candid Therapeutics is currently valued at $657.0M as of August 20, 2024. The company has raised a total of $445.0M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 1.48x, Candid Therapeutics has achieved a valuation that is 1.48 times the total capital raised.

Track Candid Therapeutics Valuation Updates

Get notified when Candid Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Candid Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Candid Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Candid Therapeutics Worth in 2026?

Candid Therapeutics is a leading private company in the Drug Discovery sector. Track Candid Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Candid Therapeutics Valuation is Determined

Private company valuations like Candid Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.